Evidence map›Paper›PMID 35295136›Full record

ReviewFrontiers in toxicology2021

Immune and Nervous Systems Interaction in Endocrine Disruptors Toxicity: The Case of Atrazine.

Valentina Galbiati, Erica Buoso, Roberta d'Emmanuele di Villa Bianca, Rosanna Di Paola, Fabiana Morroni, Giuseppe Nocentini, Marco Racchi, Barbara Viviani, Emanuela Corsini

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in toxicology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 69 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Imbalance of human CD4Archives of toxicology · 2025
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Characterization of Arsenic and Atrazine Contaminations in Drinking Water in Iowa: A Public Health Concern.International journal of environmental research and public health · 2023
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Valentina GalbiatiUniversità degli Studi di Milano, Milano, Italy.
Erica BuosoUniversità degli Studi di Pavia, Pavia, Italy.
Roberta d'Emmanuele di Villa BiancaDepartment of Pharmacy, School of Medicine, University of Naples Federico II, Naples, Italy.
Rosanna Di PaolaUniversità degli Studi di Messina, Messina, Italy.
Fabiana MorroniDepartment of Pharmacy and Biotechnology, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
Giuseppe NocentiniUniversità degli Studi di Perugia, Perugia, Italy.
Marco RacchiUniversità degli Studi di Pavia, Pavia, Italy.
Barbara VivianiUniversità degli Studi di Milano, Milano, Italy.
Emanuela CorsiniUniversità degli Studi di Milano, Milano, Italy.
University of Milan · ITUniversity of Pavia · ITUniversity of Bologna · ITUniversity of Messina · ITUniversity of Naples Federico II · ITUniversity of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endocrine disruptors (ED) are natural and anthropogenic chemicals that can interfere with hormonal systems at different levels. As such, ED-induced alterations in hormone functions have been implicated in many diseases and pathological conditions, including adverse developmental, reproductive, neurological, cardiovascular, and immunological effects in mammals. The fact that ED may compete with several endogenous hormones for multiple receptors and pathways is not always fully considered. This results in a complex response that depends on the cellular context in terms of receptors and interacting proteins and, thus, may differ between tissues and circumstances. Microglia, neurons, and other immune cells are potential targets and still underappreciated actors in endocrine disruption. Due to the large scale of this topic, this review is not intended to provide a comprehensive review nor a systematic review of chemicals identified as endocrine disruptors. It focuses on the immune-neuro-endocrine network in ED toxicity and research gaps, using atrazine as an example to highlight this complexity and the interrelationship between the immune, endocrine, and nervous systems, and ED.

Indexed as

atrazinehormonally active compoundsimmunotoxicityneurotoxicitysteroid hormones

Identifiers

PMID35295136
PMCPMC8915797
OpenAlexW3134259935

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.